Operating Lease, Right-of-Use Asset in USD of Chemomab Therapeutics Ltd. from Q4 2018 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Chemomab Therapeutics Ltd. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q2 2025.
  • Chemomab Therapeutics Ltd. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Chemomab Therapeutics Ltd. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $0 -$341K -100% 30 Jun 2025 6-K 14 Aug 2025
Q4 2024 $289K -$103K -26.3% 31 Dec 2024 6-K 14 Aug 2025
Q2 2024 $341K +$181K +113% 30 Jun 2024 6-K 21 Aug 2024
Q4 2023 $392K +$165K +72.7% 31 Dec 2023 20-F 04 Apr 2025
Q2 2023 $160K -$135K -45.8% 30 Jun 2023 6-K 14 Aug 2023
Q1 2023 $193K -$116K -37.5% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $227K -$118K -34.2% 31 Dec 2022 20-F 28 Mar 2024
Q3 2022 $261K -$98K -27.3% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $295K -$97K -24.7% 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 $309K -$88K -22.2% 31 Mar 2022 10-Q 12 May 2022
Q4 2021 $345K -$83K -19.4% 31 Dec 2021 20-F 28 Mar 2024
Q3 2021 $359K +$125K +53.4% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $392K +$117K +42.5% 30 Jun 2021 10-Q 13 Aug 2021
Q1 2021 $397K +$58K +17.1% 31 Mar 2021 10-Q 13 May 2021
Q4 2020 $428K -$771K -64.3% 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 $234K 30 Sep 2020 10-Q 16 Nov 2020
Q2 2020 $275K 30 Jun 2020 10-Q 14 Aug 2020
Q1 2020 $339K 31 Mar 2020 10-Q 07 May 2020
Q4 2019 $1.2M -$610K -33.7% 31 Dec 2019 10-K 09 Mar 2021
Q4 2018 $1.81M 01 Jan 2019 10-K 17 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.